Meclinas is a research unit, specialized in clinical trials for ambulatory drugs, psychiatric medicine, vaccinations, nutrition, cosmetics and medical devices
The center was officially established on 27 June 2023 by Ine Vercammen and Dr. Andreas Frans. Both childhood friends with a shared passion: the health of tomorrow!
For Meclinas, respect is paramount, both for the expectations of the clients of the studies, as well as for the well-being of the participants and the satisfaction of our staff.
This translates into quality and transparency which imbues us as a company as well as the working atmosphere.
Company Details
- Employees
- 15
- Founded
- -
- Address
- Stationstraat 102, Mechelen,antwerpen 2800,belgium
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.meclinas.com
- Keywords
- general medecine, psychiatry, medical devices, cosmetics, nutrition, dermatology, vaccines, vaccinology.
- HQ
- Mechelen, Antwerpen
Meclinas Questions
Meclinas's website is http://www.meclinas.com
Meclinas's LinkedIn profile is https://be.linkedin.com/company/meclinas
Meclinas has
15 employees.
View email and phone details for 15
employees at Meclinas.
Meclinas's industry is
Research Services
Meclinas's top competitors are
Deltaclinical,
Firstwave Clinical Consultancy,
Anima Research,
Sillar Clinical,
Archer Research,
Solcur,
Harmony Clinical Research Bv,
Xonar Clinical Research,
Iqvia Belux,
Ad Hoc Clinical.
Meclinas's categories are Research Services
Meclinas's founding year is 2023
